Fish oil in primary and secondary cardiovascular prevention

Ochsner Journal

Volumn 8, Issue 2, 2008, Pages 49-60

  Artham, Surya M ^a   Lavie, Carl J ^a,c   Milani, Richard V ^a   Anand, Rishi G ^a   O'Keefe, James H ^b   Ventura, Hector O ^a  

^a OCHSNER CLINIC FOUNDATION   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^c STANFORD UNIVERSITY   (United States)

Author keywords

Coronary heart disease prevention; DHA; Docosahexaenoic acid; Eicosapentaenoic acid; EPA; Fish oil; Omega 3 fatty acids

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; AMIODARONE; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; OLIVE OIL; OMEGA 3 FATTY ACID; PLACEBO; PRAVASTATIN; SIMVASTATIN; SOTALOL; SUNFLOWER OIL; WARFARIN;

ANTIARRHYTHMIC ACTIVITY; BLEEDING; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CORONARY ARTERY ATHEROSCLEROSIS; DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG MEGADOSE; FOOD INTAKE; GASTROINTESTINAL SYMPTOM; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE ARRHYTHMIA; HUMAN; ISCHEMIC HEART DISEASE; LOW DRUG DOSE; MORTALITY; NAUSEA; PREVALENCE; PROPHYLAXIS; REVIEW; SUDDEN DEATH;

EID: 47949105012     PISSN: 15245012     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (80)

1. Lavie CJ, Gau GT, Squires RW, Kottke BA. Management of lipids in primary and secondary prevention of cardiovascular diseases. Mayo Clin Proc. 1988;63:605-621.
2. Lavie CJ, O'Keefe JH, Blonde L, Gau GT. High-density lipoprotein cholesterol. Recommendations for routine testing and treatment. Postgrad Med. 1990;87:36-44, 47, 51.
3. Lavie CJ. Lipid and lipoprotein fractions and coronary artery disease. Mayo Clin Proc. 1993 Jun;68:618-619.
4. Lavie CJ, Genton E. Hemostasis, thrombosis, and antiplatelet therapy - implications for the prevention of cardiovascular diseases. Cardiovasc Rev Rep. 1991;12:24-47.
5. Lavie CJ, Schmieder R, Genton E. Antiplatelet therapy for cardiovascular diseases. Cardiovasc Rev Rep. 1987;8:64-69.
6. Lavie CJ, Schmieder R, Genton E. Hemostasis, thrombosis, and antiplatelet agents. Cardiovasc Rev Rep. 1987;8:25-29.
7. Lavie CJ, Messerli FH. Hypertension and target organ disease. In: Messserli FH, ed. The ABC's of Antihypertensive Therapy. New York: Raven Press, 1994:175-185.
8. Lavie CJ, Squires RW, Gau GT. Preventive cardiology: what is the role of fish and fish oils in primary and secondary prevention. J Cardiopulm Rehabil. 1987;7:526-533.
9. Lavie CJ, Squires RW, Gau GT. Preventive cardiology: what is the value of antiplatelet agents and fish oils? South Med J. 1988;81:1145-1150.
10. Lavie CJ, Milani RV. National Cholesterol Education Program's recommendations, and implications of "missing" high-density lipoprotein cholesterol in cardiac rehabilitation programs. Am J Cardiol. 1991;68:1087-1088.
11. Lavie CJ, Milani RV. Fish oils. In: Messerli FH, ed. Cardiovascular Drug Therapy. Philadelphia: W.B. Saunders Company, 1996:1608-1613.
12. Lavie CJ, Squires RW, Gau GT. Prevention of cardiovascular disease. Of what value are risk factor modification, exercise, fish consumption, and aspirin therapy? Postgrad Med. 1987;81:52-54, 59-72.
13. Kromhout D, Bosschieter EB, de Lezenne Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med. 1985;312:1205-1209.
14. Dolecek TA. Epidemiological evidence of relationships between dietary polyunsaturated fatty acids and mortality in the multiple risk factor intervention trial. Proc Soc Exp Biol Med. 1992;200:177-182.
15. Albert CM, Hennekens CH, O'Donnell CJ, et al. Fish consumption and risk of sudden cardiac death. JAMA. 1998;279:23-28.
16. Iso H, Rexrode KM, Stampfer MJ, et al. Intake of fish and omega-3 fatty acids and risk of stroke in women. JAMA. 2001;285:304-312.
17. Yokoyama M, Origasa H, Matsuzaki M, et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis [published correction appears in Lancet. 2007;370:220]. Lancet. 2007;369:1090-1098.
18. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial, Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico [Published corrections appear in Lancet. 2001;357: 642 and Lancet. 2007;369:106]. Lancet. 1999;354:447-455.
19. Burr ML, Fehily AM, Gilbert JF, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet. 1989;2:757-761.
20. Singh RB, Niaz MA, Sharma JP, Kumar R, Rastogi V, Moshiri M. Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival - 4. Cardiovasc Drugs Ther. 1997;11:485-491.
21. O'Keefe JH Jr, Harris WS. From Inuit to implementation: omega-3 fatty acids come of age. Mayo Clin Proc. 2000;75:607-614.
22. O'Keefe JH, Harris WS. Omega-3 fatty acids: time for clinical implementation? Am J Cardiol. 2000;85:1239-1241.
23. Sinclair HM. The diet of Canadian Indians and Eskimos. Proc Nutr Soc. 1953;12:69-82.
24. Bang HO, Dyerberg J. Plasma lipids and lipoproteins in Greenlandic west coast Eskimos. Acta Med Scand. 1972;192:85-94.
25. Bang HO, Dyerberg J. Lipid metabolism and ischemic heart disease in Greenland Eskimos. Adv Nutr Res. 1980;3:1-22.
26. Dyerberg J, Bang HO, Hjorne N. Fatty acid composition of the plasma lipids in Greenland Eskimos. Am J Clin Nutr. 1975;28:958-966.
27. Rodriguez BL, Sharp DS, Abbott RD, et al. Fish intake may limit the increase in risk of coronary heart disease morbidity and mortality among heavy smokers. The Honolulu Heart Program. Circulation. 1996;94:952-956.
28. Ascherio A, Rimm EB, Stampfer MJ, Giovannucci EL, Willett WC. Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men. N Engl J Med. 1995;332:977-982.
29. Guallar E, Hennekens CH, Sacks FM, Willett WC, Stampfer MJ. A prospective study of plasma fish oil levels and incidence of myocardial infarction in US male physicians. J Am Coll Cardiol. 1995;25:387-394.
30. Lee JH, O'Keefe JH, Lavie CJ, Marchioli R, Harris WS. Omega-3 for cardioprotection. Mayo Clin Proc. 2008;83:324-332.
31. Alaswad K, Lavie CJ, Milani RV, O'Keefe JH Jr. Fish oil in cardiovascular protection. Ochsner J. 2002;4:83-91.
32. Anand RG, Alkadri M, Lavie CJ, Milani RV. The role of fish oil in arrhythmia prevention. J Cardiopulm Rehabil Prev. 2008;28(2):92-98.
33. Marchioli R, Barzi F, Bomba E, et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation. 2002;105:1897-1903.
34. Leaf A. On the reanalysis of the GISSI-Prevenzione. Circulation. 2002;105:1874-1875.
35. Macchia A, Levantesi G, Franzosi MG, et al. Left ventricular systolic dysfunction, total mortality, and sudden death in patients with myocardial infarction treated with n-3 polyunsaturated fatty acids. Eur J Heart Fail. 2005;7:904-909.
36. von Schacky C, Angerer P, Kothny W, Theisen K, Mudra H. The effect of dietary omega-3 fatty acids on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1999;130:554-562.
37. Sacks FM, Stone PH, Gibson CM, Silverman DI, Rosner B, Pasternak RC. Controlled trial of fish oil for regression of human coronary atherosclerosis. HARP Research Group. J Am Coll Cardiol. 1995;25:1492-1498.
38. Raitt MH, Connor WE, Morris C, et al. Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial. JAMA. 2005;293:2884-2891.
39. Leaf A, Albert CM, Josephson M, et al. Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Circulation. 2005;112:2762-2768.
40. Brouwer IA, Zock PL, Camm AJ, et al. Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: the Study on Omega-3 Fatty Acids and Ventricular Arrhythmia (SOFA) randomized trial. JAMA. 2006;295:2613-2619.
41. Jacobson TA. Secondary prevention of coronary artery disease with omega-3 fatty acids. Am J Cardiol. 2006;98:61i-70i.
42. Tavazzi L, Tognoni G, Franzosi MG, et al. Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure. Eur J Heart Fail. 2004;6:635-641.
43. Mozaffarian D, Psaty BM, Rimm EB, et al. Fish intake and risk of incident atrial fibrillation. Circulation. 2004;110:368-373.
44. Calò L, Bianconi L, Colivicchi F, et al. N-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. J Am Coll Cardiol. 2005;45:1723-1728.
45. Crystal E, Garfinkle MS, Connolly SS, Ginger TT, Sleik K, Yusuf SS. Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery. Cochrane Database Syst Rev. 2004;(4):CD003611.
46. Harris WS, Pottala JV, Sands SA, Jones PG. Comparison of the effects of fish and fish-oil capsules on the n-3 fatty acid content of blood cells and plasma phospholipids. Am J Clin Nutr. 2007;86:1621-1625.
47. Block RC, Harris WS, Reid KJ, Sands SA, Spertus JA. EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls. Atherosclerosis. 2008;197:821-828. Epub 2007 Sep 17.
48. Harris WS. Omega-3 fatty acids and cardiovascular disease: a case for omega-3 index as a new risk factor. Pharmacol Res. 2007;55:217-223.
49. Albert CM, Campos H, Stampfer MJ, et al. Blood levels of longchain n-3 fatty acids and the risk of sudden death. N Engl J Med. 2002;346:1113-1118.
50. O'Keefe JH Jr, Abuissa H, Sastre A, Steinhaus DM, Harris WS. Effects of omega-3 fatty acids on resting heart rate, heart rate recovery after exercise, and heart rate variability in men with healed myocardial infarctions and depressed ejection fractions. Am J Cardiol. 2006;97:1127-1130.
51. Curtis BM, O'Keefe JH Jr. Autonomic tone as a cardiovascular risk factor: the dangers of chronic fight or flight. Mayo Clin Proc. 2002;77:45-54.
52. Ventura HO, Lavie CJ, Messerli FH, et al. Cardiovascular adaptation to cyclosporine-induced hypertension. J Hum Hypertens. 1994;8:233-237.
53. Ventura HO, Milani RV, Lavie CJ, et al. Cyclosporine-induced hypertension. Efficacy of omega-3 fatty acids in patients after cardiac transplantation. Circulation. 1993;88:II281-II285.
54. Abuissa H, O'Keefe JH Jr, Harris W, Lavie CJ. Autonomic function, omega-3, and cardiovascular risk. Chest. 2005;127:1088-1091.
55. Lavie CJ, Milani RV, Squires RW, Boykin C. Exercise and the heart. Good, benign, or evil? Postgrad Med. 1992;91:130-134, 143-150.
56. Harris WS, Gonzales M, Laney N, Sastre A, Borkon AM. Effects of omega-3 fatty acids on heart rate in cardiac transplant recipients. Am J Cardiol. 2006;98:1393-1395.
57. Mehra MR, Lavie CJ, Ventura HO, Milani RV. Fish oils produce anti-inflammatory effects and improve body weight in severe heart failure. J Heart Lung Transplant. 2006;25:834-838.
58. Endres S, Ghorbani R, Kelley VE, et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med. 1989;320:265-271.
59. Belluzzi A, Brignola C, Campieri M, Pera A, Boschi S, Miglioli M. Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med. 1996;334:1557-1560.
60. Stenson WF, Cort D, Rodgers J, et al. Dietary supplementation with fish oil in ulcerative colitis. Ann Intern Med. 1992;116:609-614.
61. Harris WS. Expert opinion: omega-3 fatty acids and bleeding: cause for concern? Am J Cardiol. 2007;99:44C-46C.
62. Goodnight SH Jr, Harris WS, Connor WE. The effects of dietary omega 3 fatty acids on platelet composition and function in man: a prospective, controlled study. Blood. 1981;58:880-885.
63. Alaswad K, Pogson GW, Harris WS. Effect of phenytoin, niacin, gemfibrozil, and omega-3 fatty acids on high density lipoproteins in patients with hypoalphalipoproteinemia. Prev Cardiol. 1999;2:141-150.
64. Backgrounder for the 2004 FDA/EPA Consumer Advisory: What you need to know about mercury in fish and shellfish. U.S. Food and Drug Administration. Available at: http://fda.gov/oc/opacom/hottopics/mercury/backgrounder.html. 2004. Accessed November 5, 2007.
65. Foran SE, Flood JG, Lewandrowski KB. Measurement of mercury levels in concentrated over-the-counter fish oil preparations: is fish oil healthier than fish? Arch Pathol Lab Med. 2003;127:1603-1605.
66. Foran JA, Hites RA, Carpenter DO, Hamilton MC, Mathews-Amos A, Schwager SJ. A survey of metals in tissues of farmed Atlantic and wild Pacific salmon. Environ Toxicol Chem. 2004;23:2108-2110.
67. Harris WS. n-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr. 1997;65(5 suppl):1645S-1654S.
68. Harris WS, Ginsberg HN, Arunakul N, et al. Safety and efficacy of Omacor in severe hypertriglyceridemia. J Cardiovasc Risk. 1997;4:385-391.
69. Harris WS. International recommendations for consumption of long-chain omega-3 fatty acids. J Cardiovasc Med. (Hagerstown). 2007;8(suppl 1):S50-S52.
70. Kris-Etherton P, Daniels SR, Eckel RH, et al. Summary of the scientific conference on dietary fatty acids and cardiovascular health: conference summary from the nutrition committee of the American Heart Association. Circulation. 2001;103:1034-1039.
71. Kris-Etherton PM, Harris WS, Appel LJ. American Heart Association. Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease [published correction appears in Circulation. 2003;107:512]. Circulation. 2002;106:2747-2757.
72. Agricultural Research Service Nutrient Data Laboratory, U.S. Department of Agriculture. Available at: http://www.nal.usda.gov/fnic/foodcomp/search/. Accessed November 1, 2007.
73. Reed SA. More on fish oil [letter]. N Engl J Med. 1987;316:625.
74. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
75. World Health Organization, Diet, Nutrition, and the Prevention of Chronic Diseases: Report of a Joint WHO/FAO Expert Consultation. Technical report No. 916. Geneva: World Health Organization. 2003.
76. Priori SG, Aliot E, Blomstrom-Lundqvist C, et al. Update of the guidelines on sudden cardiac death of the European Society of Cardiology. Eur Heart J. 2003;24:13-15.
77. Van de Werf F, Ardissino D, Betriu A, et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J. 2003;24:28-66.
78. De Backer G, Ambrosioni E, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J. 2003;24:1601-1610.
79. UK Scientific Advisory Committee on Nutrition, Advice on Fish Consumption Benefits and Risks. London, United Kingdom: The Stationery Office. 2004.
80. Franz MJ, Bantle JP, Beebe CA, et al. Nutrition principles and recommendations in diabetes. Diabetes Care. 2004;27(suppl 1):S36-S46.